Scott Baker, OD - Medicare Optometrist in Cold Spring, KY

Scott Baker, OD is a medicare enrolled "Optometrist" provider in Cold Spring, Kentucky. He went to Ohio State University - College Of Optometry and graduated in 2009 and has 15 years of diverse experience with area of expertise as Optometry. He is a member of the group practice Phoenix Ophthalmologists Pa and his current practice location is 339 Crossroads Blvd, Cold Spring, Kentucky. You can reach out to his office (for appointments etc.) via phone at (859) 441-9464.

Scott Baker is licensed to practice in Ohio (license number 5839) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1558591321.

Contact Information

Scott Baker, OD
339 Crossroads Blvd,
Cold Spring, KY 41042
(859) 441-9464
Not Available



Healthcare Provider's Profile

Full NameScott Baker
GenderMale
SpecialityOptometry
Experience15 Years
Location339 Crossroads Blvd, Cold Spring, Kentucky
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Scott Baker attended and graduated from Ohio State University - College Of Optometry in 2009
  NPI Data:
  • NPI Number: 1558591321
  • Provider Enumeration Date: 07/15/2009
  • Last Update Date: 03/19/2017
  Medicare PECOS Information:
  • PECOS PAC ID: 7416003082
  • Enrollment ID: I20140811001131

Medical Identifiers

Medical identifiers for Scott Baker such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1558591321NPI-NPPES
4116OtherAZLAST 4 NUMBERS OF CELL PHONE

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist 5839 (Ohio)Primary
152W00000XOptometrist 1831DT (Kentucky)Secondary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Phoenix Ophthalmologists Pa27694691543

News Archive

Estrogen may also play a role in migraine for men

While it has been known that estrogen plays a role in migraine for women, new research shows that the female sex hormone may also play a role in migraine for men, according to a small study published in the June 27, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Drug for midnight waking gets FDA approval

Transcept Pharmaceuticals Inc. has received the Food and Drug Administration (FDA) approval for its drug Intermezzo - a drug that can help people get back to sleep after waking in the middle of the night. The treatment contains a low-dose of zolpidem tartrate, the active ingredient in Paris-based Sanofi's sleeping pill Ambien.

Underwriters partially exercise over-allotment option in Cadence public offering

Cadence Pharmaceuticals, Inc. today announced that its underwriters partially exercised their over-allotment option in connection with its previously announced public offering that priced on November 11, 2010, by purchasing an additional 1,000,000 shares of its common stock at a public offering price of $8.00 per share. Including the over-allotment shares purchased, Cadence sold a total of 12,500,000 shares in the offering, resulting in expected aggregate gross proceeds to the company of $100 million.

Experienced criminals find new opportunities in medical fraud

Gangsters are getting into the medical fraud business, CNN reports. "Experienced in running drug, prostitution and gambling rings, crime groups of various ethnicities and nationalities are learning it's safer and potentially more profitable to file fraudulent claims with the federal Medicare program and state-run Medicaid plans."

ICTP to participate in QWeCl project to help fight malaria and other vector-borne illnesses

The Abdus Salam International Centre for Theoretical Physics is taking part in a newly-launched, major international, European Union-funded project to help fight malaria and other vector-borne illnesses by developing and deploying an early warning system for disease outbreaks in Africa.

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Scott Baker allows following entities to bill medicare on his behalf.
Provider NamePhoenix Ophthalmologists Pa
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1356377873
PECOS PAC ID: 2769469154
Enrollment ID: O20120829000907

News Archive

Estrogen may also play a role in migraine for men

While it has been known that estrogen plays a role in migraine for women, new research shows that the female sex hormone may also play a role in migraine for men, according to a small study published in the June 27, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Drug for midnight waking gets FDA approval

Transcept Pharmaceuticals Inc. has received the Food and Drug Administration (FDA) approval for its drug Intermezzo - a drug that can help people get back to sleep after waking in the middle of the night. The treatment contains a low-dose of zolpidem tartrate, the active ingredient in Paris-based Sanofi's sleeping pill Ambien.

Underwriters partially exercise over-allotment option in Cadence public offering

Cadence Pharmaceuticals, Inc. today announced that its underwriters partially exercised their over-allotment option in connection with its previously announced public offering that priced on November 11, 2010, by purchasing an additional 1,000,000 shares of its common stock at a public offering price of $8.00 per share. Including the over-allotment shares purchased, Cadence sold a total of 12,500,000 shares in the offering, resulting in expected aggregate gross proceeds to the company of $100 million.

Experienced criminals find new opportunities in medical fraud

Gangsters are getting into the medical fraud business, CNN reports. "Experienced in running drug, prostitution and gambling rings, crime groups of various ethnicities and nationalities are learning it's safer and potentially more profitable to file fraudulent claims with the federal Medicare program and state-run Medicaid plans."

ICTP to participate in QWeCl project to help fight malaria and other vector-borne illnesses

The Abdus Salam International Centre for Theoretical Physics is taking part in a newly-launched, major international, European Union-funded project to help fight malaria and other vector-borne illnesses by developing and deploying an early warning system for disease outbreaks in Africa.

Read more Medical News

› Verified 7 days ago

Provider NameEstrella Mountain Eye Care Pllc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1912443888
PECOS PAC ID: 3678856234
Enrollment ID: O20170207000377

News Archive

Estrogen may also play a role in migraine for men

While it has been known that estrogen plays a role in migraine for women, new research shows that the female sex hormone may also play a role in migraine for men, according to a small study published in the June 27, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Drug for midnight waking gets FDA approval

Transcept Pharmaceuticals Inc. has received the Food and Drug Administration (FDA) approval for its drug Intermezzo - a drug that can help people get back to sleep after waking in the middle of the night. The treatment contains a low-dose of zolpidem tartrate, the active ingredient in Paris-based Sanofi's sleeping pill Ambien.

Underwriters partially exercise over-allotment option in Cadence public offering

Cadence Pharmaceuticals, Inc. today announced that its underwriters partially exercised their over-allotment option in connection with its previously announced public offering that priced on November 11, 2010, by purchasing an additional 1,000,000 shares of its common stock at a public offering price of $8.00 per share. Including the over-allotment shares purchased, Cadence sold a total of 12,500,000 shares in the offering, resulting in expected aggregate gross proceeds to the company of $100 million.

Experienced criminals find new opportunities in medical fraud

Gangsters are getting into the medical fraud business, CNN reports. "Experienced in running drug, prostitution and gambling rings, crime groups of various ethnicities and nationalities are learning it's safer and potentially more profitable to file fraudulent claims with the federal Medicare program and state-run Medicaid plans."

ICTP to participate in QWeCl project to help fight malaria and other vector-borne illnesses

The Abdus Salam International Centre for Theoretical Physics is taking part in a newly-launched, major international, European Union-funded project to help fight malaria and other vector-borne illnesses by developing and deploying an early warning system for disease outbreaks in Africa.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Scott Baker is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Scott Baker, OD
7241 W Kings Ave,
Peoria, AZ 85382-4948

Ph: (937) 371-4116
Scott Baker, OD
339 Crossroads Blvd,
Cold Spring, KY 41042

Ph: (859) 441-9464

News Archive

Estrogen may also play a role in migraine for men

While it has been known that estrogen plays a role in migraine for women, new research shows that the female sex hormone may also play a role in migraine for men, according to a small study published in the June 27, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Drug for midnight waking gets FDA approval

Transcept Pharmaceuticals Inc. has received the Food and Drug Administration (FDA) approval for its drug Intermezzo - a drug that can help people get back to sleep after waking in the middle of the night. The treatment contains a low-dose of zolpidem tartrate, the active ingredient in Paris-based Sanofi's sleeping pill Ambien.

Underwriters partially exercise over-allotment option in Cadence public offering

Cadence Pharmaceuticals, Inc. today announced that its underwriters partially exercised their over-allotment option in connection with its previously announced public offering that priced on November 11, 2010, by purchasing an additional 1,000,000 shares of its common stock at a public offering price of $8.00 per share. Including the over-allotment shares purchased, Cadence sold a total of 12,500,000 shares in the offering, resulting in expected aggregate gross proceeds to the company of $100 million.

Experienced criminals find new opportunities in medical fraud

Gangsters are getting into the medical fraud business, CNN reports. "Experienced in running drug, prostitution and gambling rings, crime groups of various ethnicities and nationalities are learning it's safer and potentially more profitable to file fraudulent claims with the federal Medicare program and state-run Medicaid plans."

ICTP to participate in QWeCl project to help fight malaria and other vector-borne illnesses

The Abdus Salam International Centre for Theoretical Physics is taking part in a newly-launched, major international, European Union-funded project to help fight malaria and other vector-borne illnesses by developing and deploying an early warning system for disease outbreaks in Africa.

Read more News

› Verified 7 days ago


Optometrist in Cold Spring, KY

Spencer Gabbard, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 339 Crossroads Blvd, Cold Spring, KY 41076
Phone: 859-441-9464    
Myeyedr.
Optometrist
Medicare: Medicare Enrolled
Practice Location: 339 Crossroads Blvd., Cold Spring, KY 41076
Phone: 859-441-9464    Fax: 859-442-2023
Wing Eyecare
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 339 Crossroads Blvd, Cold Spring, KY 41076
Phone: 859-441-9464    Fax: 859-442-2023
Ritesh B Patel, O.D.
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 339 Crossroads Blvd, Cold Spring, KY 41076
Phone: 859-441-9464    
Family First Vision Care Kentucky, Llc
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 4318 Alexandria Pike, Cold Spring, KY 41076
Phone: 859-474-8159    
Dr. Douglas Newport Thompson, OD
Optometrist
Medicare: Medicare Enrolled
Practice Location: 4318 Alexandria Pike, Cold Spring, KY 41076
Phone: 859-474-8159    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.